In breast cancer the genes at the most telomeric part of the amplicon, ERLIN2 and ZNF703, display the higher frequency of amplification (11.8% and 11.7% of breast cancer cases, respectively), while the frequency of amplification decreases in more centromeric genes of 8p11.23 locus (Table 3). This evidence concerns the gene ERLIN2 and breast cancer.